bruno (L12) Flashcards
explain purigenic signaling
intercellular signalling involving purine based molecules
purines: adenine, atp, adp, theobromine, caffeine, adenosine etc
conversion from atp to adenosine
When you lose Phos from atp and you get conversion to adenosine → disadvantageous to the cell, turns off the energy demanding processes (adenosine does this)
purigenic nerves
nerves that use purines as a neurotransmitter
Atp can be used as a neurotransmitter
necessities to consider a molecule as a neurotransmitter
formation and storage of ATP
release of purine nucleotides
direct actions of purine nucleotides and nucleosides on smoot muscle
inactivation of ATP
antagonism and potentiation of responses to nerve stimulation and ATP
purine production, release, metabolism and receptors
DIAGRAM IN L12 S5
Atp released from cells by endocytosis
Stored in presynaptic vesicles
Found in extracellular space, can activate receptors (like P2x and P2y), gets converted in extracellular space to give rise to different molecules (adp, amp or adenosine)
Interconversion of amp and adenosine (adenosine can be phosphorylated to give rise to AMP)
adenosine kinase by turning adenosine into AMP can create an inwards gradient for adenosine uptake
This produces a gradient for the atp to leak out of the cell
Equilibrative transporter pump, pumps atp down its concentration gradient
why is purinergic signalling complex?
multiple receptors and signalling mechanisms
Atp activates P2X receptors
7 diff subunits in P2X (forms a polymer)
P2Y receptors are activated by many diff ligands
8 diff types of P2Y receptors (some are better activated by atp, some by adp, some by glucose)
Endogeneous ligands for P2Y receptors
Adenine receptor called P0
Adenosine receptor is P1 (4 diff types of P1)
adenosine as a drug
purine receptors can be used as drug targets
Adenosine used to treat heart diseases
ATP as a neurotransmitter in muscles
ATP is a neurotransmitter at AUTONOMIC NEUROEFFECTOR JUNCTIONS
Twitches in the muscle - excitatory junctions in the muscle
Alpha beta methylene ATP will desensitises the p2x receptors for reduction of size of these responses
Increase conc for more reduction in size
High conc you get an even greater reduction in response to nerve stimulation
Small peaks (bottom line) are spontaneous release of atp from synaptic vesicles Disappear when you desensitise the receptors of atp (P2X)
EVIDENCE THAT ATP RELEASE IS USED AS A NEUROTRANSMITTER
Diagram on top right - varicosities with larger vesicles having neuropeptides and smaller vesicles having atp
Activate the receptors - ion channel gives rise to excitatory junction potential which can increase the influx of calcium and lead to smooth muscle contraction
Spontaneous twitching (excitatory) Stimulation of the nerve stops activity - AP is occuring in the muscle, it is spontaneously twitching. If you stimulate the nerve, you get a hyperpolarization of the membrane and stop the twitching and contraction
identification of P2X mediated synaptic transmission in the medial habenula of the brain
Recordings of synaptic transmissions at medial habenula
Apply diff compounds
When we block nicotinic receptors, they wont have any effect
Diff compound that affects the p2 receptors allows us to inhibit the actions of the agonists on these receptors
This suggests that the receptors that mediate this response are P2X and P2Y receptors
Purinergic transmitters are found in the hippocampus
Block glutamatergic transmission (synaptic transmission mediated by glutamate receptors) to discover the component of synaptics transmission that are sensitive to P2 receptor antagonists
so he showed that in the hippocampus and the cortex we find synaptic transmission mediated by the activation of p2x receptors
ATP P2X receptors
ATP P2X RECEPTOR FAMILY
trimeric, so 3 subunits join to form an ion channel
both N and C terminals of the polypeptide chain is in the intracellular space
GLUTAMATE RECEPTOR FAMILY
GABA receptors are also part of this family, also form a receptor when its 4 subunits come together so is tetrameric
has the N terminal extracellular / C terminal intracellular
NICOTINIC RECEPTOR SUPERFAMILY
Nicotinic acetyl receptors - pentameric, 5 subunits join to form an ion channel
5HT3 receptors are ionotropic, also pentameric
—-»> In all these receptors, TM2 (transmembrane 2) actually creates the ion channel
molecular architecture of trimeric ATP P2X and its ion access routes
Ion permeable pathway through the receptors to the pore of the hP2X4R
These ionotric receptors are like drain pipes through the membrane (from top to the bottom, orange in A)
Nicotinic receptors instead have a very ion dense area at the bottom so the ions would flow out through the sides
Fenestrations for the ions to flow in could be from the sides (orange in B)
purinergic signalling to cause analgesia
ANALGESIA VIA P2X ANTAGONISTS OR A1 AGONISTS
purinergic signalling can take place in the peripheral and central pain pathways
Inject atp into someone’s skin will stimulate p2x receptors
If you use a1 agonists can induce analgesia
Atp activates the p2x receptors
Stimulate pain sensing fibres
Conversion of atp to adenosine to bind to a1 receptors
chronic cough
Use of P2X3 antagonists to suppress the coughing effectively
Chronic cough condition - overstimulation of p2x3 receptors
P2X7 receptor in pain and cell death
Shows improvement in abdominal pain and in general wellbeing
Useful in this one condition
P2X7R when activated under normal conditions doesn’t cause anything
Activated with very high concentrations of atp - this is when these pathological conditions take place
Sodium or potassium influx can stimulate cell death cascade
A property of p2x7r - properties of the receptor change with increased stimulation which gives rise to more ionic influx - coupled to another receptor through which more ions can flow
Not likely to dilate, conductance is quite high
Coupling to another protein can mediate additional ionic influx
other functions of the P2X7 receptor
P2X7 receptors are unusual because they have a cytoplasmic ballast
this large protein entity on the c-terminal site of the receptor does not have a clear function
it is not an ion permeation pathway because it looks like the ions are getting through defenestrations on the side of the receptor
receptor is regulated for when it is is palmitoylated
so it does not desensitize in the presence of ATP
so when you remove the palmitoylations, then you get a desensitization receptor